Former FDA Chiefs Encourage Collection of RWE
May 26, 2020
Former Food and Drug Administration chiefs Mark McClellan and Scott Gottlieb urged greater incentives for the collection of real-world evidence to support COVID-19 therapies, Inside Health Policy reports.
To read the full report, click here.